These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14441432)

  • 1. Effect of phenylacetic acid on the carcinoid syndrome.
    SANDLER M; DAVIES A; RIMINGTON C
    Lancet; 1959 Sep; 2(7098):318-22. PubMed ID: 14441432
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical effect of phenylacetic acid in a patient with 5-hydroxytryptophan-secreting carcinoid tumor.
    SANDLER M; CLOSE HG
    Lancet; 1959 Sep; 2(7098):316-8. PubMed ID: 14441431
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy of the malignant carcinoid syndrome.
    Kvols LK
    Endocrinol Metab Clin North Am; 1989 Jun; 18(2):557-68. PubMed ID: 2663485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a serotonin antagonist (UML 491) in carcinoid disease.
    PEART WS; ROBERTSON JI
    Lancet; 1961 Nov; 2(7213):1172-4. PubMed ID: 14484792
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of pharmacologic treatment in the malignant carcinoid syndrome.
    URELES AL; MURRAY M; WOLF R
    N Engl J Med; 1962 Aug; 267():435-8. PubMed ID: 13923917
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of methyldopa in carcinoid disease.
    NICHOLSON GI; IRVINE RO
    Br Med J; 1962 Oct; 2(5310):961-3. PubMed ID: 14479461
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of pyridoxine antagonists in the carcinoid syndrome.
    SCHRODT GR; DIZON FY; PESKOE LY; HOWELL RS; ROBIE CH; STEVENSON TD
    Am Pract Dig Treat; 1960 Sep; 11():750-5. PubMed ID: 14443602
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observations on a case of carcinoid syndrome. Anti-serotonin treatment after resection of the small intestine].
    LANZ R
    Schweiz Med Wochenschr; 1960 Sep; 90():1046-8. PubMed ID: 15445408
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the therapeutic use of alpha-methyl-DOPA in the carcinoid syndrome].
    DUBACH UC; BLUMBERG A
    Klin Wochenschr; 1961 Sep; 39():973. PubMed ID: 13888006
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of carcinoid syndrome, with an account of the use of alpha-methyl-dopa.
    NOBLE NR
    Med J Aust; 1961 Oct; 48(2)():589-92. PubMed ID: 14480157
    [No Abstract]   [Full Text] [Related]  

  • 11. Malignant carcinoid syndrome and latest concepts in serotonin metabolism; use of cortisone, prednisone and antiserotonin compound 45-50.
    GAILITIS RJ; SCHEIBER W
    Am J Surg; 1960 Jan; 99():84-9. PubMed ID: 13825944
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin treatment in a case of carcinoid tumour.
    AUSTERN H; JOHANSSON SA; LUNDBERG A; SJOBERG HE
    Acta Med Scand; 1960 Dec; 168():367-9. PubMed ID: 13685202
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on several possible antiserotonin compounds in a patient with the functioning carcinoid syndrome.
    VROOM FQ; BROWN RE; DEMPSEY H; HILL SR
    Ann Intern Med; 1962 Jun; 56():941-5. PubMed ID: 13926919
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of carcinoid and the carcinoid syndrome].
    Rasenack U; Caspary W
    Dtsch Med Wochenschr; 1983 Apr; 108(17):671-3. PubMed ID: 6188602
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Malignant carcinoid syndrome.
    Med J Aust; 1974 Nov; 2(21):765. PubMed ID: 4453233
    [No Abstract]   [Full Text] [Related]  

  • 16. Some newer aspects of the carcinoid syndrome.
    Eiband JM; Brown H; Gregory CH; Kahil ME
    Tex Med; 1966 Dec; 62(12):62-5. PubMed ID: 5980426
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of alpha-methyl-dopa (alpha-methyl-3,4-dihydroxy-DL-phenylalanine) in the management of the carcinoid syndrome.
    COLLINI FJ
    N Engl J Med; 1961 May; 264():986-7. PubMed ID: 13694731
    [No Abstract]   [Full Text] [Related]  

  • 18. Emerging treatment options for carcinoid syndrome.
    Kulke MH
    Clin Adv Hematol Oncol; 2016 Sep; 14(9):666-7. PubMed ID: 27673284
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of serotonin antagonists in the treatment of the malignant carcinoid syndrome.
    WEAVER WR; METZ EN; ANLYAN WG; RUNDLES WR
    Surg Forum; 1961; 12():330-2. PubMed ID: 14005403
    [No Abstract]   [Full Text] [Related]  

  • 20. Transcatheter arterial chemoembolization with DSM for primary hepatic malignant carcinoid.
    Hijioka S; Ikari T; Kamei A; Takano K; Asahara S; Fujita N; Shimizu M; Kuraoka K; Fijita R; Kanda H; Kato Y
    Hepatogastroenterology; 2007 Mar; 54(74):382-5. PubMed ID: 17523279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.